{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:14:06Z","timestamp":1718896446288},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Health Econom"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1007\/s10198-002-0097-6","type":"journal-article","created":{"date-parts":[[2003,3,24]],"date-time":"2003-03-24T21:48:06Z","timestamp":1048542486000},"page":"111-119","source":"Crossref","is-referenced-by-count":16,"title":["Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine"],"prefix":"10.1007","volume":"3","author":[{"given":"Lukas","family":"Radbruch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-H.","family":"Gockel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Neighbors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nuyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"key":"97_CR1","doi-asserted-by":"crossref","unstructured":"Ahmedzai S, Brooks D (1997) Transdermal fentanyl versus sustained release morphine in cancer pain: preference, efficacy and quality of life. J Pain Symptom Manage 13:254\u2013261","DOI":"10.1016\/S0885-3924(97)00082-1"},{"key":"97_CR2","unstructured":"Ahmedzai S, Allan E, Fallon M, et al (1994) Transdermal fentanyl in cancer pain. J Drug Dev 6:93\u201397."},{"key":"97_CR3","doi-asserted-by":"crossref","unstructured":"Allan L,Hays H, Jensen N-H, et al (2001) Randomised crossover trial of transdermal fentanyl and oral morphine in chronic non-cancer pain.BMJ 322:1154\u20131158","DOI":"10.1136\/bmj.322.7295.1154"},{"key":"97_CR4","unstructured":"Anonymous (1999) Physician\u2019s desk reference. Medical Economics: Montvale"},{"key":"97_CR5","doi-asserted-by":"crossref","unstructured":"Bala MV,Wood LL, Zarkin GA, et al (1998) Valuing outcomes in health care: a comparison of willingness-to-pay and quality-adjusted life-years. J Clin Epidemiol 51:667\u2013676","DOI":"10.1016\/S0895-4356(98)00036-5"},{"key":"97_CR6","doi-asserted-by":"crossref","unstructured":"Bloor K, Leese B,Maynard A (1994) The costs of managing severe cancer pain and potential savings from transdermal administration. Eur J Cancer 30A:463\u2013468","DOI":"10.1016\/0959-8049(94)90420-0"},{"key":"97_CR7","unstructured":"Broglie M, Schade H-J, Gerhardt G (1997) Geb\u00fchrenhandbuch-Kommentare f\u00fcr \u00c4rzte EBM GO\u00c4.Medical Tribune"},{"key":"97_CR8","doi-asserted-by":"crossref","unstructured":"Dellemijn PLI, van Duijn H,Vanneste JAL (1998) Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage 16:220\u2013229","DOI":"10.1016\/S0885-3924(98)00070-0"},{"key":"97_CR9","doi-asserted-by":"crossref","unstructured":"Donner B,Zenz M,Tryba M, Strumpf M (1996) Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain.Pain 64:527\u2013534","DOI":"10.1016\/0304-3959(95)00180-8"},{"key":"97_CR10","doi-asserted-by":"crossref","unstructured":"Drossman DA,Corazziari E,Talley NJ, et al (1999) Rome II: a multinational consensus document on functional gastrointestinal disorders. Gut 45 [Suppl II]:1\u201381","DOI":"10.1136\/gut.45.2008.ii1"},{"key":"97_CR11","doi-asserted-by":"crossref","unstructured":"Grond S,Zech D, Lehmann KA, et al (1997) Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region.Pain 69:191\u2013198","DOI":"10.1016\/S0304-3959(96)03254-X"},{"key":"97_CR12","doi-asserted-by":"crossref","unstructured":"Grond S,Radbruch L, Lehmann KA (2000) Clinical pharmacokinetics of transdermal opioids.Focus on transdermal fentanyl. Clin Pharmacokinet 38:59\u201389.","DOI":"10.2165\/00003088-200038010-00004"},{"key":"97_CR13","doi-asserted-by":"crossref","unstructured":"Gureje O,Von Korff M, Simon G,Gater R (1998) Persistent pain and well-being: a World Health Organization study in primary care.JAMA 280:147\u2013151","DOI":"10.1001\/jama.280.2.147"},{"key":"97_CR14","doi-asserted-by":"crossref","unstructured":"Hanks GW, de Conno F, Cherny N, et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 85:587\u2013593","DOI":"10.1054\/bjoc.2001.1680"},{"key":"97_CR15","unstructured":"Hannoveraner Konsens Gruppe (1999) Deutsche Empfehlungen zur gesundheits\u00f6konomischen Evaluation \u2014 revidierte Fassung des Hannoveraner Konsens.Gesundheits\u00f6kon Qualit\u00e4tsmanage 4:3,A62\u2013A65"},{"key":"97_CR16","unstructured":"Iconomou G,Viha A,Vagenakis AG,Kalofonos HP (2000) Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination. Anticancer Res 20:4821\u20134824"},{"key":"97_CR17","doi-asserted-by":"crossref","unstructured":"Jeal W,Benfield P (1997) Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.Drugs 53:109\u2013138","DOI":"10.2165\/00003495-199753010-00011"},{"key":"97_CR18","doi-asserted-by":"crossref","unstructured":"Lehmann KA,Zech D (1992) Transdermal fentanyl: clinical pharmacology. J Pain Symptom Manage 7: S8\u2013S16","DOI":"10.1016\/0885-3924(92)90048-M"},{"key":"97_CR19","doi-asserted-by":"crossref","unstructured":"Levy MH, Rosen SM,Kedziera P (1992) Transdermal fentanyl: seeding trial in patients with chronic cancer pain. J Pain Symptom Manage 7 [Suppl]:48\u201350","DOI":"10.1016\/0885-3924(92)90054-L"},{"key":"97_CR20","unstructured":"Liebau K (1999) Berufskunde f\u00fcr Heilpraktiker. Pflaum: Munich"},{"key":"97_CR21","doi-asserted-by":"crossref","unstructured":"Milligan K, Lanteri-Minet M,Borchert K, et al (2001) Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic non-cancer pain. J Pain 2:197\u2013204","DOI":"10.1054\/jpai.2001.25352"},{"key":"97_CR22","doi-asserted-by":"crossref","unstructured":"Neighbors DM,Bell TJ,Wilson J,Dodd SC (2001) Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain. J Pain Symptom Manage 21:129\u2013143","DOI":"10.1016\/S0885-3924(00)00247-5"},{"key":"97_CR23","doi-asserted-by":"crossref","unstructured":"Newshan G, Lefkowitz M (2001) Transdermal fentanyl for chronic pain in AIDS: a pilot study. J Pain Symptom Manage 21:69\u201377","DOI":"10.1016\/S0885-3924(00)00238-4"},{"key":"97_CR24","doi-asserted-by":"crossref","unstructured":"Payne R, Chandler S, Einhaus M (1995) Guidelines for the clinical use of transdermal fentanyl. Anticancer Drugs 6 [Suppl 3]:50\u201353","DOI":"10.1097\/00001813-199504003-00009"},{"key":"97_CR25","doi-asserted-by":"crossref","unstructured":"Radbruch L, Sabatowski R, Loick G, et al (2000) Constipation and the use of laxatives \u2014 a comparison between transdermal fentanyl and oral morphine.Palliat Med 14:111\u2013119","DOI":"10.1191\/026921600671594561"},{"key":"97_CR26","doi-asserted-by":"crossref","unstructured":"Radbruch L, Sabatowski R,Petzke F, et al (2001) Transdermal fentanyl for the management of cancer pain \u2014 a survey of 1005 patients. Palliat Med 15:309\u2013321","DOI":"10.1191\/026921601678320296"},{"key":"97_CR27","unstructured":"Roback B,Thirlwell M,Cowans M, et al (1995) Potential cost savings with fentanyl patches in comparison to oral or parenteral opioid: a pilot study.Presented at the American Pain Society General Meeting, September 1995,Montreal, Canada"},{"key":"97_CR28","unstructured":"Rote Liste Service GmbH (1999) Rote Liste 1999.Cantor: Aulendorf"},{"key":"97_CR29","unstructured":"Rote Liste Service GmbH (2000) Rote Liste 2000.Cantor: Aulendorf"},{"key":"97_CR30","doi-asserted-by":"crossref","unstructured":"Schofferman J (1993) Long term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage 8:279\u2013288","DOI":"10.1016\/0885-3924(93)90156-P"},{"key":"97_CR31","doi-asserted-by":"crossref","unstructured":"Simmonds MA (1995) Transdermal fentanyl: clinical development in the United States. Anticancer Drugs 6 [Suppl 3]:35\u201338","DOI":"10.1097\/00001813-199504003-00006"},{"key":"97_CR32","doi-asserted-by":"crossref","unstructured":"Simpson RK, Edmondson EA,Constant CF, Collier C (1997) Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manage 14:218\u2013224","DOI":"10.1016\/S0885-3924(97)00183-8"},{"key":"97_CR33","unstructured":"Slappendel R, Lako SJ, Crul BJP (1994) Gastrointestinal side effects diminish after switch over from morphine to transdermal fentanyl.Ann Oncol 5 [Suppl 8]:200"},{"key":"97_CR34","doi-asserted-by":"crossref","unstructured":"Slover R (1992) Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center. J Pain Symptom Manage 7 [Suppl]:S45\u2013S47","DOI":"10.1016\/0885-3924(92)90053-K"},{"key":"97_CR35","unstructured":"Tooley PJH,Cookson RF, Jones M, Nuyts GD (2000) Medical events and resource utilisation in cancer-pain patients treated with strong opioids: an analysis of the UK General Practice Database. J Outcomes Res 4:1\u201314"},{"key":"97_CR36","unstructured":"Woodroffe MA,Hays H (1997) Fentanyl transdermal system.Pain management at home. Can Fam Physician 43:268\u2013272"},{"key":"97_CR37","unstructured":"Zech DFJ, Lehmann KA,Grond S (1994) A new treatment option for chronic cancer pain.Eur J Palliat Care 1:26\u201330"},{"key":"97_CR38","doi-asserted-by":"crossref","unstructured":"Zenz M, Strumpf M,Tryba M (1992) Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 7:69\u201377","DOI":"10.1016\/0885-3924(92)90116-Y"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-002-0097-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-002-0097-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-002-0097-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:56:04Z","timestamp":1559127364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-002-0097-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["97"],"URL":"https:\/\/doi.org\/10.1007\/s10198-002-0097-6","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}